Five-year interval is safe for prostate cancer screening, research shows

A simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.

Sat, 6 Apr 2024
OncologyProstate CancerEAU 24Early DetectionPSA Test

The PSA blood test checks the level of prostate-specific antigen, a marker for prostate cancer. In Europe, only Lithuania routinely screens men for prostate cancer based on their PSA levels, as the test has historically been seen as insufficiently reliable.

The German study, presented at the European Association of Urology (EAU) Congress in Paris today [April 6, 2024], involved over 12,500 men aged between 45-50 taking part in the ongoing PROBASE trial, which is testing different prostate cancer screening protocols.